Keratify

Keratify is a biotechnology company that provides a high-fidelity, ex vivo human skin testing platform designed to address the limitations of standard laboratory skin models. By maintaining whole human skin tissue in a lab environment, the company's patented technology allows for more accurate measurement of key biological processes, helping to overcome issues such as rapid tissue deterioration and poor predictive accuracy found in many 3D skin models and animal-based tests. The platform is designed to provide results that better mimic real human skin responses, which is critical for reducing errors in toxicology and compound testing.

This technology is particularly valuable for companies in the cosmetics, pharmaceutical, and medical device sectors that need to conduct dermatology research and development without relying on animal testing. By offering more reliable, human-relevant data, Keratify enables organizations to streamline their R&D processes, navigate regulatory requirements more effectively, and improve the development of new dermatological therapeutics and skin care products. The company currently provides these specialized capabilities through bespoke contract research services.